Your browser doesn't support javascript.
loading
Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial.
Zheng, Yanqing; Dou, Huiqin; Li, Qingchen; Sun, Ying; Wang, Yanchao; Zhang, Wendong.
Afiliación
  • Zheng Y; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Dou H; Department of Stomatology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Li Q; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Sun Y; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Wang Y; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Zhang W; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Cancer Control ; 28: 1073274821997444, 2021.
Article en En | MEDLINE | ID: mdl-34029149
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cisplatino / Paclitaxel / Cetuximab / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cisplatino / Paclitaxel / Cetuximab / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China